Aspirin at therapeutic concentrations does not inhibit the uptake of 5-hydroxytryptamine (5-HT) by blood platelets nor induce release of 5-HT from platelets, although platelet aggregation responses to collagen and arachidonic acid (which are dependent on platelet prostaglandin synthesis) are abolished. This does not support an earlier claim that aspirin's effects on platelet function include inhibition of 5-HT transport.
Introduction Aspirin at plasma concentrations of 0.1-1 mM inhibits prostaglandin-dependent platelet aggregation and secretion (for review, see Smith & Silver, 1977) . Rendu (1976) showed that 1.1 mM aspirin inhibited the uptake of 5-hydroxytryptamine (5-HT) by human platelets, and suggested that this action might contribute significantly to the spectrum of aspirin's inhibitory effects on platelets. A subsequent correction (Erratum: Br. J. Pharmac. (1976) , 58 (1)) indicated that an aspirin concentration of 110 mM had in fact been used in these experiments, but this correction did not explain how a concentration of 110 mM aspirin (which greatly exceeds the drug's aqueous solubility) was achieved in a physiological medium, and therefore more methodological details of these experiments are needed to evaluate the results adequately. In addition, the question originally addressed by Rendu (1976) remained unanswered-does aspirin at therapeutic concentrations affect 5-HT uptake by platelets? We therefore measured the uptake of 5-HT by platelets in plasma samples with up to 1 mM aspirin added, and in samples from volunteers who had ingested aspirin. described by Drummond & Gordon (1976) . Briefly, 0.1 ml samples of PRP were incubated with 5-hydroxy-[G-3H1-tryptamine creatinine sulphate (0.5 Ci/mmol; The Radiochemical Centre, Amersham), final concentration 1 gM, at 37°C for 2 min except where otherwise stated. Uptake was terminated by addition of 0.5 ml ice cold iso-osmotic saline containing 0.4% (w/v) disodium edetate (EDTA) and centrifuging immediately (14,700g; 30 seconds). The cell pellet was washed with 1 ml iso-osmotic saline and the uptake of 5-HT determined by liquid scintillation counting of the radioactivity in the pellet. A 5-HT concentration of 1 giM was chosen because this is the apparent Km value for 5-HT uptake by human platelets under these conditions (Gordon & Olverman, 1976) .
Platelet aggregation was measured photometrically (Born, 1962) in 0.1 ml samples of PRP (Gordon & Drummond, 1974) . Agents used to induce platelet aggregation were fibrillar collagen (10 gg/ml) and arachidonic acid (1 mM). Both of these agents stimulate platelets by activating prostaglandin synthesis.
For studies in vitro aspirin (final concentrations 5-1000 gM) was preincubated in PRP at 370C for 10 minutes. For studies ex vivo, PRP was prepared from volunteers immediately before and 2 h after ingestion of 900 mg aspirin. The platelet count in each sample was adjusted to 3.5 x 108 cells/ml.
Results Uptake of 5-HT 2 h after ingestion of aspirin was unaltered (Figure la [3H]-5-HT transported was (mean + s.e.) 143+3 pmol/I08 cells (n = 6). 
